IL-2–inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cells is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: P20 GM135000
NIAID NIH HHS
Grant: R01 AI138570
NCI NIH HHS
Grant: R21 CA283872
NIAID NIH HHS
Grant: R01 AI120701
FWCI
2.36
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals